SANTA ROSA, Calif., July 24, 2017 /PRNewswire/ -- Millipede, Inc., a leader in device innovations for mitral and tricuspid disease, today announced the continuation of its catheter based mitral implant series. Millipede successfully implanted its newest 50-millimeter IRIS annuloplasty ring with a transfemoral, transseptal delivery catheter in a functional mitral regurgitation (FMR) patient. "We are excited to introduce this newest implant size to allow inclusion of a larger patient population," stated Randy Lashinski, Millipede's President and CEO.
"The new 50-millimeter diameter IRIS implant allows easier placement and more robust annular reduction of the large-diameter mitral annuli that are typically seen in severe functional mitral regurgitation. This rapid iteration by the Millipede team of the device and delivery system has markedly improved ease of use and expands the treatable patient population," noted Dr. Jason Rogers, Professor of Cardiovascular Medicine, UC Davis.
Furthermore, as part of Millipede's clinical experience, a MitraClip (Abbott) was used successfully following a previously placed Millipede IRIS (18 months post implantation). The patient was clinically stable for 15 months following the Millipede therapy and re-presented three months ago with a torn chord due to progressive degenerative disease. A single MitraClip, placed inside the Millipede IRIS, resolved the chordal issue. "Compatibility with existing transcatheter therapies, for both DMR and FMR patients, is an important feature of the Millipede IRIS," said Dr. Rogers.
The Millipede IRIS is the only complete and adjustable ring that allows the physician to size and adjust for the patient's anatomy and valve geometry. The IRIS ring is also repositionable and retrievable during the implant procedure adding an additional dimension of safety to the procedure for physicians and their patients.
About Millipede, Inc.
Millipede, Inc. (www.millipedemedical.com) is a medical device company based in Santa Rosa, California with the goal of providing catheter delivery of the gold standard in heart valve repair – a complete annuloplasty ring.
View original content with multimedia:http://www.prnewswire.com/news-releases/millipede-inc-announces-first-cases-with-50mm-transcatheter-annuloplasty-ring-expanding-treatable-patient-population-300492675.html
SOURCE Millipede, Inc.